Finally, as it was limited to four cSCC cell lines, our study cannot provide a final answer to the question of whether targeting specific PI3K(s) might represent a therapeutic strategy in cSCC, especially considering the many cross talks between this pathway and other signaling cascades. This evidence concerns the gene PIK3CA and skin squamous cell carcinoma.